Targeting nucleolin for better survival in diffuse large B-cell lymphoma

Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature

(2016) Maud-Emmanuelle Gilles et al.   CANCER RESEARCH

Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs

(2016) Rohit Mathur et al.   HAEMATOLOGICA

AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol–Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non–Small Cell Lung Cancer In Vitro

(2016) Mona Alibolandi et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs

(2016) Rohit Mathur et al.   HAEMATOLOGICA

The roles of nucleolin subcellular localization in cancer

(2015) Caroline Madeleine Berger et al.   BIOCHIMIE

Molecular difference between WASP and N-WASP critical for chemotaxis of T-cells towards SDF-1α

(2015) Neeraj Jain et al.   Scientific Reports

A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy

(2015) Thu Le Trinh et al.   PLoS One

Cell Surface Nucleolin as a Target for Anti-Cancer Therapies

(2014) Marina Koutsioumpa et al.   Recent Patents on Anti-Cancer Drug Discovery

Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer

(2013) Wensheng Qiu et al.   APMIS

Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex

(2013) J. F. Wise et al.   BLOOD

In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation

(2013) Flavia Pichiorri et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Nucleolin Interacts with the Dengue Virus Capsid Protein and Plays a Role in Formation of Infectious Virus Particles

(2013) C. A. Balinsky et al.   JOURNAL OF VIROLOGY

Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription

(2013) Y.-L. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Nucleolin mediates nucleosome disruption critical for DNA double-strand break repair

(2013) M. Goldstein et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

(2012) Z. Y. Xu-Monette et al.   BLOOD

Cancer treatment and survivorship statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Inhibition of ATM blocks the etoposide-induced DNA damage response and apoptosis of resting human T cells

(2012) Z. Korwek et al.   DNA REPAIR

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

(2012) C. Visco et al.   HAEMATOLOGICA

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

(2012) C Visco et al.   LEUKEMIA

Nucleolin Participates in DNA Double-Strand Break-Induced Damage Response through MDC1-Dependent Pathway

(2012) Junya Kobayashi et al.   PLoS One

RNA-binding protein nucleolin in disease

(2012) Kotb Abdelmohsen et al.   RNA Biology

Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type

(2011) Bernard Krust et al.   BMC CANCER

A Simple Approach to Cancer Therapy Afforded by Multivalent Pseudopeptides That Target Cell-Surface Nucleoproteins

(2011) D. Destouches et al.   CANCER RESEARCH

Peptidyl Prolyl Isomerase, Pin1 is a Potential Target for Enhancing the Therapeutic Efficacy of Etoposide

(2011) R. Mathur et al.   CURRENT CANCER DRUG TARGETS

Topo IIα gene alterations correlated with survival in patients with diffuse large B-cell lymphoma

(2011) Zhenwen Chen et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Identification of nucleolin as a cellular receptor for human respiratory syncytial virus

(2011) Farnoosh Tayyari et al.   NATURE MEDICINE

Ku70 and Rad51 vary in their importance for the repair of doxorubicin- versus etoposide-induced DNA damage

(2010) Ilona Schonn et al.   APOPTOSIS

DNA Topoisomerase II Enzymes as Molecular Targets for Cancer Chemotherapy

(2010) K. Chikamori et al.   CURRENT CANCER DRUG TARGETS

Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy

(2010) Michael F. Press et al.   JOURNAL OF CLINICAL ONCOLOGY

γH2AX: a sensitive molecular marker of DNA damage and repair

(2010) L-J Mah et al.   LEUKEMIA

High levels of topoisomerase IIα protein expression in diffuse large B-cell lymphoma are associated with high proliferation, germinal center immunophenotype, and response to treatment

(2010) George Pentheroudakis et al.   LEUKEMIA & LYMPHOMA

Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature

(2009) Valentina Fogal et al.   ANGIOGENESIS

Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer

(2009) Paula J. Bates et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

The DNA-damage response in human biology and disease

(2009) Stephen P. Jackson et al.   NATURE

Diffuse Large B-Cell Lymphoma

(2008) Jonathan W. Friedberg et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Stromal Gene Signatures in Large-B-Cell Lymphomas

(2008) G. Lenz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Casein kinase I  /  phosphorylates topoisomerase II  at serine-1106 and modulates DNA cleavage activity

(2008) A. G. Grozav et al.   NUCLEIC ACIDS RESEARCH